Reported Earlier, Structure Therapeutics Prices Upsized $476M Public Offering 9,066,972 American Depositary Shares At $52.50/ADS
Author: Benzinga Newsdesk | June 06, 2024 02:20am
Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary diseases, today announced the pricing of its upsized underwritten public offering of 9,066,972 American depositary shares (ADSs), each representing three ordinary shares, at a public offering price of $52.50 per ADS. The aggregate gross proceeds to Structure Therapeutics from the offering are expected to be approximately $476.0 million, before deducting underwriting discounts and commissions and offering expenses.
Posted In: GPCR